'The Growing Importance of Community Oncology Data for Brand Managers and Commercial Teams'
An estimated 85% of cancer patients in the United States are treated in the community setting by oncologists who treat a wide range of cancers. This white paper discusses why community oncology data is a crucial tool for brand and commercial teams, the growing importance of biomarker data and how physician-level data can inform brand strategy.
Learn how to:
Refine your market segmentation
Craft evidence-based value propositions
Enhance your marketing strategies to stay ahead in the competitive oncology market
Discover the strategic advantages of integrating biomarker data for personalized cancer treatments
Fill out form to download community oncology white paper
